platinum has been researched along with Bone Marrow Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Areberg, J; Björkman, S; Johansson, L; Johnsson, A; Mattsson, S; Norrgren, K; Sjölin, M | 1 |
| Cooney, DA; Davis, RD; Fleischman, RW; Heyman, IA; Ilievski, V; Phelan, R; Rosenkrantz, H; Schaeppi, U | 1 |
2 other study(ies) available for platinum and Bone Marrow Diseases
| Article | Year |
|---|---|
Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin (191Pt) in Wistar rats.
Topics: Animals; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Female; Kidney Diseases; Platinum; Radioisotopes; Random Allocation; Rats; Rats, Wistar | 2006 |
cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.
Topics: Amines; Animals; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Chlorine; Dehydration; Dogs; Haplorhini; Hypoxia; Injections, Intravenous; Lethal Dose 50; Lymphatic Diseases; Mice; Necrosis; Organometallic Compounds; Pain; Platinum; Time Factors; Vomiting | 1973 |